Agneta Siegbahn Selected Research

Growth Differentiation Factor 15

6/2022	Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
11/2021	Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
1/2021	Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.
1/2021	Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
11/2020	Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
1/2020	ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
1/2020	Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
12/2019	Interleukin-18 in patients with acute coronary syndromes.
1/2019	Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes.
12/2018	Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agneta Siegbahn Research Topics

Disease

51	Stroke (Strokes) 12/2021 - 11/2011
46	Acute Coronary Syndrome 06/2022 - 03/2003
46	Myocardial Infarction 06/2022 - 02/2002
42	Atrial Fibrillation 01/2022 - 04/2012
34	Hemorrhage 01/2022 - 03/2007
28	Inflammation (Inflammations) 06/2022 - 08/2002
26	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 10/2002
15	Heart Failure 06/2022 - 07/2003
15	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 07/2003
15	Embolism (Embolus) 12/2020 - 04/2012
13	Neoplasms (Cancer) 01/2020 - 01/2008
13	Thrombosis (Thrombus) 01/2020 - 05/2003
11	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2013
10	Atherosclerotic Plaque (Atheroma) 12/2021 - 05/2008
7	Necrosis 06/2022 - 10/2002
7	Atherosclerosis 01/2020 - 02/2012
6	Heart Diseases (Heart Disease) 04/2016 - 04/2007
5	ST Elevation Myocardial Infarction 06/2022 - 12/2003
5	Chronic Renal Insufficiency 12/2021 - 01/2012
5	Diabetes Mellitus 11/2019 - 01/2006
4	Ischemia 12/2020 - 07/2003
4	Ischemic Stroke 12/2020 - 12/2015
3	Fibrosis (Cirrhosis) 06/2022 - 01/2017
3	Infections 01/2022 - 01/2014
3	COVID-19 01/2022 - 11/2020
3	Carcinogenesis 01/2021 - 01/2011
3	Obesity 12/2019 - 09/2013
3	Death (Near-Death Experience) 02/2015 - 06/2013
2	Vascular Calcification 11/2021 - 12/2020
2	Peripheral Arterial Disease 09/2021 - 08/2017
2	Dyslipidemias (Dyslipidemia) 01/2020 - 10/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 11/2016
2	Sudden Death 10/2018 - 01/2017
2	Hypertension (High Blood Pressure) 10/2017 - 01/2014
2	Pulmonary Embolism 02/2017 - 12/2015
2	Transient Ischemic Attack 11/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

68	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2003
28	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 07/2003
27	Growth Differentiation Factor 15IBA 06/2022 - 10/2007
26	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 07/2003
20	apixabanIBA 01/2021 - 04/2012
18	Troponin T (Troponin T1)IBA 06/2022 - 03/2003
17	Cystatin CIBA 01/2022 - 01/2012
16	Clopidogrel (Plavix)FDA Link 04/2022 - 05/2006
15	C-Reactive ProteinIBA 06/2022 - 03/2003
15	Interleukin-6 (Interleukin 6)IBA 06/2022 - 12/2003
15	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 04/2012
14	TroponinIBA 01/2021 - 03/2003
12	Thromboplastin (Tissue Factor)IBA 11/2019 - 10/2002
11	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2011
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 02/2004
9	TicagrelorIBA 04/2022 - 11/2012
9	AnticoagulantsIBA 11/2021 - 04/2007
8	darapladibIBA 12/2021 - 01/2016
8	Troponin IIBA 01/2021 - 04/2012
8	Dalteparin (Dalteparin Sodium)FDA Link 02/2010 - 05/2003
7	CreatinineIBA 01/2020 - 04/2004
7	fibrin fragment D (D-dimer)IBA 11/2017 - 02/2002
7	Dabigatran FDA Link 06/2016 - 11/2011
5	Trinitrotoluene (TNT)IBA 06/2022 - 03/2003
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020 - 03/2006
5	CholesterolIBA 11/2013 - 03/2006
5	Heparin (Liquaemin)FDA LinkGeneric 01/2011 - 02/2002
5	Prasugrel Hydrochloride FDA Link 07/2009 - 05/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2002
4	LigandsIBA 01/2021 - 01/2016
4	Biological ProductsIBA 11/2020 - 12/2014
4	oxidized low density lipoproteinIBA 02/2020 - 03/2006
4	LDL CholesterolIBA 01/2020 - 03/2006
4	Thrombin FDA Link 01/2019 - 02/2004
4	Factor VIIa (Activated Factor VII)IBA 01/2016 - 04/2014
4	Triglycerides (Triacylglycerol)IBA 11/2013 - 03/2006
3	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2011
3	FibrinIBA 03/2020 - 01/2018
3	HDL LipoproteinsIBA 02/2020 - 03/2006
3	LDL Lipoproteins (beta Lipoproteins)IBA 11/2019 - 03/2006
3	CD40 Ligand (CD40L)IBA 10/2017 - 07/2006
3	Natriuretic PeptidesIBA 02/2017 - 06/2013
3	CytokinesIBA 01/2017 - 10/2002
3	Vitamin K FDA Link 04/2016 - 04/2012
3	LipidsIBA 11/2013 - 03/2006
3	histidine-rich proteinsIBA 10/2013 - 11/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2008 - 10/2002
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022 - 12/2015
2	Trefoil Factor-3IBA 01/2022 - 12/2020
2	Fibroblast Growth Factor-23IBA 01/2022 - 01/2021
2	Angiotensin-Converting Enzyme 2IBA 01/2022 - 11/2020
2	factor V LeidenIBA 01/2021 - 01/2021
2	AdrenomedullinIBA 01/2021 - 12/2015
2	OsteoprotegerinIBA 01/2021 - 12/2018
2	PTX3 proteinIBA 06/2020 - 12/2015
2	Interleukin-18 (Interleukin 18)IBA 12/2019 - 06/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2017 - 12/2011
2	InterleukinsIBA 01/2017 - 10/2002
2	trans-crotonin (CTN)IBA 06/2016 - 05/2016

Therapy/Procedure

26	Therapeutics 12/2021 - 11/2011
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 08/2002
5	Percutaneous Coronary Intervention 06/2022 - 01/2007
3	Stents 01/2020 - 01/2007